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Aims The risk of mortality from the coronavirus disease that emerged in 2019 (COVID-19) is increased by comorbidity
from cardiovascular and pulmonary diseases. Air pollution also causes excess mortality from these conditions.
Analysis of the first severe acute respiratory syndrome coronavirus (SARS-CoV-1) outcomes in 2003, and prelimi-
nary investigations of those for SARS-CoV-2 since 2019, provide evidence that the incidence and severity are
related to ambient air pollution. We estimated the fraction of COVID-19 mortality that is attributable to the long-




We characterized global exposure to fine particulates based on satellite data, and calculated the anthropogenic
fraction with an atmospheric chemistry model. The degree to which air pollution influences COVID-19 mortality
was derived from epidemiological data in the USA and China. We estimate that particulate air pollution contributed
15% (95% confidence interval 7–33%) to COVID-19 mortality worldwide, 27% (13 – 46%) in East Asia, 19% (8–
41%) in Europe, and 17% (6–39%) in North America. Globally, 50–60% of the attributable, anthropogenic fraction
is related to fossil fuel use, up to 70–80% in Europe, West Asia, and North America.
....................................................................................................................................................................................................
Conclusion Our results suggest that air pollution is an important cofactor increasing the risk of mortality from COVID-19. This
provides extra motivation for combining ambitious policies to reduce air pollution with measures to control the
transmission of COVID-19.
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1. Introduction
Poor air quality, especially from fine particulate matter with a diameter
<2.5 mm (PM2.5), is one of the leading risk factors, and responsible for
many excess deaths.1,2 The global loss of life expectancy from long-term
exposure to ambient air pollution exceeds that of infectious diseases,
and is comparable with that of tobacco smoking.1–3 The mortality from
COVID-19 depends on comorbidities, including conditions that increase
cardiovascular risks such as arterial hypertension, diabetes mellitus, obe-
sity, and established coronary artery disease, as well as respiratory
conditions such as asthma and chronic obstructive pulmonary disease
(COPD), being similar to those that are influenced by air pollution.3–6
The risk of death is strongly related to age, being particularly high in
those aged >70. It is also higher amongst males, economically disadvan-
taged populations, and in some ethnic groups. In assessing the relation-
ships between exposures to risk factors and outcomes, potential
confounders therefore need to be accounted for in the design of studies
and in data analysis. These include the age distribution of the population,
availability of hospital beds (and intensive care capacity), and the propor-
tion of the population living in poverty.
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A recent study, using an ecological design, assessed how environmen-
tal influences modify the severity of COVID-19 outcomes in the USA.7
Potential confounders were identified, and statistical models were used
to relate long-term exposure to ambient PM2.5 to COVID-19 deaths.
The computed mortality rate ratios (MRRs) express the relative increase
in COVID-19 deaths for each microgram per cubic meter increment of
PM2.5 in ambient air. The PM2.5 data were derived from satellite and
ground-based measurements combined with atmospheric modelling,8
and the confounders were determined from county-level censuses,
homeland infrastructure, and meteorological data. Here we test the as-
sumption that the derived MRRs are representative for the populations
of other countries (China) and consider the global impact. In the present
study, we apply the MRRs to estimate the excess mortality, i.e. the frac-
tion of COVID-19 deaths that could be avoided if the population were
exposed to lower counterfactual air pollution levels without fossil fuel-
related and other anthropogenic emissions. We emphasize that our
results are provisional, based on epidemiological data collected up to the
third week of June 2020, and a comprehensive evaluation will need to
follow after the COVID-19 pandemic.
1.1 SARS and air pollution
In the early 2000s, the first severe acute respiratory syndrome coronavi-
rus (SARS-CoV-1) appeared in China (Guangdong Province). The virus
was zoonotic, as it originally developed in bats.9 The World Health
Organization (WHO) reported that it resulted in a SARS epidemic with
>8000 cases in 26 countries, mostly in south-east Asia and in Canada.8
The disease emerged in November 2002 and was contained in July 2003.
SARS-CoV-1 and SARS-CoV-2 have many similarities, as their RNA
genomes are closely related and the viruses enter the host cells by bind-
ing to the same entry receptor angiotensin-converting enzyme 2
(ACE2).10–12 About 2–14 days after infection, the systemic symptoms of
both diseases are alike, and a similar fraction of patients develops severe
symptoms with a mortality rate that increases strongly with advanced
age.13–16 In China alone, >5000 cases of SARS-CoV-1 were reported,
leading to nearly 350 fatalities. Since the exposure to ambient air pollu-
tion is associated with respiratory and cardiovascular diseases, it was hy-
pothesized that health outcomes of SARS were aggravated by poor air
quality. A study in 2003 corroborated that in parts of China with moder-
ate levels of air pollution, the risk of dying from the disease was >80%
higher compared with areas with relatively clean air, while in heavily pol-
luted regions the risk was twice as high.17
1.2 COVID-19 and air pollution
In 2019, the related second virus strain appeared (SARS-CoV-2) in
China (Hubei Province), which also developed in bats,4 causing COVID-
19, which grew from an epidemic into a pandemic in the early part of
2020. A Chinese analysis indicated that the risk of symptomatic infection
typically increases by 4% for each year of age between 30 and 60, and
that the lethality is highest for individuals >60 years.15COVID-19 is asso-
ciated with a combination of respiratory and cardiovascular complica-
tions, which may comprise myocardial infarction, heart failure, venous
thrombo-embolisms, and increases in biomarkers,18 which are also
found in connection with high levels of air pollutants.5 In a recent analysis
of 5700 patients hospitalized with COVID-19 in the New York City
area, the most common comorbidities were hypertension (57%), obesity
(42%), and diabetes (34%),19 representing cardiovascular risk factors
that are also observed in relation to elevated PM2.5 concentrations,
5,20
suggesting additive or synergistic effects on the cardiovascular system. In
addition, advanced age is a strong risk factor for cardiovascular disease,
and the effects on immune function may be equally important for
COVID-19 susceptibility. The age dependency coincides with that of ex-
cess mortality from PM2.5.
3,15 The COVID-19 mortality rate has been es-
timated to be 4% in symptomatic cases, in part because pre-existing
conditions such as cardiovascular and respiratory disorders increase the
risk.21
Considering the cardiovascular and respiratory health impacts of air
pollution, the relationship to COVID-19 mortality is not unexpected.
Preliminary studies addressed the influence of air pollution on COVID-
19 in different regions. In China, the incidence of COVID-19 was found
to be significantly enhanced by PM2.5,
22 while a correlation between am-
bient PM2.5 and the mortality rate was also established.
23 In Italy, it was
found that the high pollution concentrations that are typical for the Po
valley, especially in the Lombardy region of which Milan is the capital,
were associated with a high mortality rate.24 As mentioned above, in the
USA the severity of COVID-19 outcomes was linked to PM2.5 exposure,
making use of Medicare data for >60 million people and nationwide air
quality measurements.7 Data were collected for 98% of the population
in 3087 of the total number of 3142 counties, of which 42% had
reported COVID-19 deaths up to the third week of April 2020. The
death counts relied on data from the Coronavirus Resource Center of
the Johns Hopkins University.25 The study accounted for 20 potential
confounding factors including population size, age distribution, popula-
tion density, time period since the beginning of the outbreak, time
elapsed since the home confinements, hospital beds, number of individu-
als tested, meteorological conditions, and socioeconomic and risk fac-
tors such as obesity and smoking.7 The results showed significant
overlap between the causes of death in COVID-19 patients and those
that lead to mortality from PM2.5. The MRR, i.e. the percentage increase
of COVID-19 mortality risk per mg/m3 increase of exposure to PM2.5,
was found to be 8%, with a 95% confidence interval of 2–15%.7 The cal-
culations are continually updated based on the most recent data (up to
18 June at the time of writing), showing no significant changes in the MRR
in the preceding 4 months.
2. Methods
2.1 Global model and data
We applied a global atmospheric chemistry general circulation model
(EMAC) which comprehensively simulates atmospheric chemical and meteo-
rological processes and interactions with the oceans and the biosphere, in
the same set-up as in recent studies on climate change, air pollution, and pub-
lic health.3,26 In addition to the standard simulation, we performed two sensi-
tivity calculations: (i) with fossil fuel-related emissions removed and (ii) with
all anthropogenic emissions removed. The model results were used to esti-
mate the ratio of fine particulates in simulation (i) and (ii) and the standard
simulation. The annual atmospheric near-surface PM2.5 concentrations were
taken from model-integrated satellite data, for the year 2019.8,27 The hori-
zontal resolution is 0.01 by 0.01 degrees, corresponding to a grid size of 1
km  1 km. The near-surface concentrations of PM2.5 for fossil fuel-related
and all anthropogenic emissions are estimated by scaling this data set to the
ratios (i) and (ii) obtained with the EMAC model simulations.
2.2 Relative risk
To estimate the relative risk (RR or hazard ratio) of excess COVID-19 mor-
tality from the long-term exposure to air pollution, we used the exposure–
response function of the WHO,28














































RR is a function of the concentration of air pollutants, which specifies an-
nual average exposure dependent on location (grid cell) derived from the
data mentioned above. X is the pollutant (PM2.5) and X0 is the pollutant
threshold concentration below which exposure does not have implications
for public health. Both b and X0 are estimated by fitting to data from the liter-
ature with a least square method (Figure 1). We adopted the threshold PM2.5
concentration (X0) from Burnett et al.
2 (i.e. < 2.4 lg/m3 PM2.5), forcing the
curve fitting into this range. We tested different exposure–response func-
tions, e.g. of Burnett et al.,2 and values for X0, and find that the results are not
sensitive to these assumptions.
Because the COVID-19 mortality rate ratio due to air pollution, based on
data in the USA alone,7 may not represent countries with very high fine parti-
cle concentrations (associated with a lack of observations in such regions),
we investigated the effect of including data from the enhanced mortality rate
derived for the Chinese SARS epidemic in 2003.17 We make the assumption
that SARS and COVID-19 mortality are similarly affected by long-term expo-
sure to air pollution. Since the analysis for SARS was based on the Chinese
Air Pollution Index (API), we converted the API to PM2.5 concentrations fol-
lowing empirical relationships from the literature.29,30 The large uncertainty
range in the fitting function to a large degree derives from those in these rela-
tionships (black squares and ranges in Figure 1). In spite of uncertainties, the
curves for the USA only and those that include the Chinese results are al-
most identical, providing confidence in the function derived for conditions in
the USA only.
2.3 Attributable fraction
We calculated RR globally using PM2.5 distributions calculated under the
standard scenario. The attributable fraction (AF) of COVID-19 mortality to
air pollution is calculated from the RR by AF = 1 – 1/RR. From the globally
distributed, gridded AFs, we aggregated into regional and country-level AFs,
weighted according to the population density, in order to account for the
varying population distributions within regions and countries. The population
data for the year 2020 were obtained from the NASA Socioeconomic Data
and Applications Center (SEDAC), hosted by the Columbia University
Center for International Earth Science Information Network (CIESIN).31
Our definition of AF does not imply a direct cause–effect relationship be-
tween air pollution and COVID-19 mortality (although it is possible). Instead
it refers to relationships between the two, direct and indirect, i.e. by aggravat-
ing comorbidities that could lead to fatal health outcomes of the virus
infection.
3. Results
3.1 Attribution of COVID-19 mortality
To estimate the AF from exposure to ambient PM2.5 to COVID-19 mor-
tality, we used the epidemiological data from the USA (red curve in
Figure 1). The chronic exposure to PM2.5 in the years prior to the
COVID-19 outbreak was estimated on the basis of satellite observations
over the year 2019. The anthropogenic and fossil fuel-related fractions
were calculated with the global EMAC model. Here we focus on anthro-
pogenic and fossil fuel-related PM2.5 to determine the impact of poten-
tially avoidable air pollution on COVID-19 mortality. Figure 2 and Table 1
present the average fractions of COVID-19 mortality attributed to the
exposure to PM2.5 pollution, both globally and regionally. Table S1 (avail-
able as Supplementary material online) lists the results for all countries.
To account for the different population distributions within countries,
e.g. between rural and urban areas, the averages have been weighted
accordingly.
In regions with strict air quality standards and relatively low levels of
air pollution, such as Australia, the attributable fraction by human-made
air pollution to COVID-19 mortality is found to be a few percent only.
Relatively high fractions occur in parts of east Asia (35%), central
Europe (25%), and eastern USA (25%). The country-level contribu-
tion to COVID-19 that we find for China, i.e. 27% (95% confidence inter-
val 13 – 47%), agrees well with that found for the SARS epidemic in
2003.17 The largest country-average fractions are found in the Czech
Republic, Poland, China, North Korea, Slovakia, Austria, Belarus, and
Germany, all above 25% (Supplementary material, Table S1). Globally,
anthropogenic air pollution contributes 15% (7 – 33%) to COVID-19
mortality, which could have been largely prevented, for example by
adopting the air quality regulations applied in Australia (annual PM2.5 limit
of 8 mg/m3). The global mean contribution of fossil fuel use to the anthro-
pogenic fraction is 56%, being highest in North America (83%), West
Asia (75%), and Europe (68%) (Table 1).
4. Discussion
4.1 Pathophysiological aspects
Both the air pollutant PM2.5 and the SARS-CoV-2 virus enter the lungs
via the bronchial system (portal organ), with potential systemic health
impacts through the blood circulation. Both PM2.5 and SARS-CoV-2
cause vascular endothelial dysfunction, oxidative stress, inflammatory
responses, thrombosis, and an increase in immune cells.32–36 The SARS-
CoV-2 infection facilitates the induction of endothelial inflammation in
Figure 1 Exposure-response dependencies, based on a log-normal
relationship28. The relative risk (or hazard ratio), from which the attrib-
utable fraction has been derived, is based on mortality rate ratios attrib-
uted to air pollution in the COVID-19 pandemic7 and the SARS
epidemic17, indicated by the black bullet and squares, respectively. The
triangle represents the threshold concentration below which
PM2.5does not have health implications
2. The red curves depict the
function fitted to the data from COVID-19 in the USA only7, plus the
threshold2 (triangle and bullet). The blue curves depict the function fit-
ted to all data2,7,17. The colored ranges show the 95% confidence inter-
vals, which are wider after including the SARS-related results (blue),










































































..several organs as a direct consequence of viral cytotoxic effects and the
host inflammatory response, which can aggravate pre-existing chronic
respiratory and vascular (coronary) dysfunction, and cause lung injury by
alveolar damage, as well as stroke and myocardial infarction by inducing
plaque rupture.37 Potential common pathophysiological mechanisms of
increased risk thus relate to endothelial injury33,38 and pathways that reg-
ulate immune function.39,40 Further, there are strong indications of in-
creased susceptibility to viral infections from exposure to air
pollution.41–46
Lung injuries, including the life-threatening acute respiratory distress
syndrome and respiratory failure, as well as acute coronary syndrome,
arrhythmia, myocarditis, and heart failure, were shown to be clinically
dominant, leading to critical complications of COVID-19.47,48 Recent
studies in China, the USA, as well as Europe indicate that patients with
cardiovascular risk factors or established cardiovascular disease and
other comorbid conditions are predisposed to myocardial injury during
the course of COVID-19.19,46,49–52 From the available information, it
thus follows that air pollution-induced inflammation leads to greater vul-
nerability and less resiliency, and the pre-conditions increase the host
vulnerability. Air pollution causes adverse events through myocardial in-
farction and stroke, and it is an additional factor capable of increasing
blood pressure, while there is emerging evidence for a link with type 2 di-
abetes and a possible contribution to obesity and enhanced insulin resis-
tance.36 Bronchopulmonary and cardiovascular pre-conditions, including
hypertension, diabetes, coronary artery disease, cardiomyopathy,
asthma, COPD, and acute lower respiratory illness, all negatively influ-
enced by air pollution, lead to a substantially higher mortality risk in
COVID-19. Furthermore, it seems likely that fine particulates prolong
the atmospheric lifetime of infectious viruses, thus favouring transmis-
sion.53 It is possible that future research will reveal additional pathways
that mediate the relationship between air pollution and the risk of death
from COVID-19.
Figure 2 Estimated percentages of COVID-19 mortality attributed to air pollution from all anthropogenic sources (top), and from fossil fuel use only
(bottom). The regions with high attributable fractions coincide with high levels of air pollution. The mapped results account for population density, thus
reflecting population weighted exposure to PM2.5.































































Our results indicate that the long-term exposure to high levels of fine
particulate matter is a significant cofactor that influences the severity of
COVID-19 outcomes. Since PM2.5 in China and the USA, from which ep-
idemiological data have been used, is dominated by anthropogenic sour-
ces that are potentially preventable, we focus our analysis on this
fraction of PM2.5. The good agreement of our results for the USA and
China is in line with recent studies, showing that the association between
air pollution and excess mortality is valid for many different countries.2,55
Nevertheless, the calculations of RRs (hazard ratios) and the AF to mor-
tality rely on the use of data from an ecological study design that has limi-
tations, even though 19 county-level variables and one state-level
variable, some of which are more important than air pollution, were con-
sidered as potential confounders in the analysis—and the PM2.5 expo-
sure data have been extensively cross-validated.7 However, we
acknowledge that residual confounding cannot be excluded. While
cross-sectional ecological studies do not allow conclusions about cause–
effect relationships, the biological mechanisms of air pollution-related
disorders, acting as comorbidities in COVID-19, are well docu-
mented.56,57 Recent studies in England and The Netherlands corrobo-
rate the positive relationships between air pollution and the number of
COVID-19 cases, hospital admissions, and mortality.58–60 The reported
MRRs for PM2.5 range from 1–7% to 13–21% (we applied 2–15%), which
confirms the significant role of air pollution but emphasizes the large un-
certainty ranges. Furthermore, our approach is likely to realistically ap-
proximate the contribution of fossil fuels and other anthropogenic
sources to the total excess deaths through long-term ambient PM2.5 air
pollution exposure.
We reiterate that the data used for China are associated with substan-
tial uncertainty, and underly the assumption that comorbidity and mor-
tality from air pollution in COVID-19 are the same as in SARS.
Nonetheless, using these data does not change the results, providing
confidence in the robustness of our findings. We emphasize that the
data relevant to the present study are from upper-middle and high-
income countries, and the representativeness of our results for low-
income countries may be limited, and uncertainties are likely to exceed
the 95% confidence intervals. It is expected that in countries with high
levels of aeolian dust, e.g. in Africa and West Asia, PM2.5 pollution is also
a cofactor but with less contribution from human activities. Household
air pollution is also likely to be important, being of particular relevance in
low-income countries.61 It will be critical to collect epidemiological evi-
dence from many regions with different socio-economic and environ-
mental conditions, to support analyses of the COVID-19 pandemic and
investigate the role of environmental factors. The uncertainty ranges
that accompany our results are considerable but, taking into account the
biological plausibility of the relationship and the strong evidence of the
impact of air pollution on conditions that are known to increase
COVID-19 mortality, they can nevertheless inform policy decisions.
4.3 Short- and long-term health impacts
A new, though preliminary, finding of the present study is that a signifi-
cant fraction of worldwide COVID-19 mortality is attributable to an-
thropogenic air pollution, of which50 – 60% is related to fossil fuel use
(70 – 80% in Europe, West Asia, and North America). This represents
potentially avoidable, excess mortality. The links between economic ac-
tivity, traffic, energy use, and public health have been illustrated by the
strong reduction of air pollution in many locations during the lockdown
measures.62,63 There is ample evidence for a relationship between short-
term exposure to PM2.5 and adverse health effects, including excess
mortality from cardiovascular and respiratory diseases.55 While it is in
principle possible to disentangle the acute from the chronic outcomes
from short- and long-term exposure to air pollution,64 at this stage it is
difficult to make that distinction for PM2.5-induced comorbidity and mor-
tality from COVID-19. Generally, short-term associations between air
pollution and mortality are substantially less than those from long-term
exposure, due to the more persistent, cumulative effects from the lat-
ter.65 By relating air pollution anomalies to short-term health outcomes
during the COVID-19-induced societal lockdown, it was found that in
China alone >4600 excess deaths may have been avoided.62 This can be
viewed as a health co-benefit from the containment measures, which
may reduce air pollution-induced COVID-19 mortality. Such benefits
could also be achieved after the COVID-19 lockdown. Both perspec-
tives of air pollution during the pandemic underscore the important role
of fossil fuel-related and other anthropogenic emissions.
4.3 Future directions
Our results suggest the potential for substantial benefits from reducing
air pollution exposure even at relatively low PM2.5 levels. Refinement of
the exposure–response relationship and reducing uncertainties will re-
quire additional data analyses, including from large cohort studies as the
COVID-19 pandemic evolves, but may appear too late to guide
........................................................................................................................
..............................................................................................................................................................................................................................
Table 1 Regional percentages of COVID-19 mortality attributed to fossil fuel-related and all anthropogenic sources of air
pollution
Region Population (million) COVID-19 mortality fraction attributed to air pollution (%)
Fossil fuel-related emissions All anthropogenic emissions
Europe 628 13 (6–33) 19 (8–41)
Africa 1345 2 (1–19) 7 (3–25)
West Asia 627 6 (3–25) 8 (4–27)
South Asia 2565 7 (3–22) 15 (8–31)
East Asia 1685 15 (8–32) 27 (13–46)
North America 525 14 (6–36) 17 (6–39)
South America 547 3 (1–23) 9 (4–30)
Oceania 28 1 (0–20) 3 (1–23)
World 7950 8 (4–25) 15 (7–33)
The 95% confidence levels are given in parentheses.

























































































decision-making. A lesson from our environmental perspective of the
COVID-19 pandemic is that the quest for effective policies to reduce an-
thropogenic emissions, which cause both air pollution and climate
change, needs to be accelerated. The pandemic ends with the vaccina-
tion of the population or with herd immunity through extensive infection
of the population. However, there are no vaccines against poor air qual-
ity and climate change. The remedy is to mitigate emissions. The transi-
tion to a green economy with clean, renewable energy sources will
further both environmental and public health locally through improved
air quality and globally by limiting climate change.
Supplementary material
Supplementary material is available at Cardiovascular Reseach online.
Funding
We thank the Mainz Heart Foundation for continuous support. T.M. is the
principal investigator of the DZHK (German Center for Cardiovascular
Research), Partner Site Rhine-Main, Mainz, Germany.
Conflict of interest: none declared.
Data availability
The data underlying this article will be shared upon reasonable request to
the corresponding author.
References
1. Cohen AJ, Brauer M, Burnett R, Anderson HR, Frostad J, Estep K, Balakrishnan K,
Brunekreef B, Dandona L, Dandona R, Feigin V, Freedman G, Hubbell B, Jobling A,
Kan H, Knibbs L, Liu Y, Martin R, Morawska L, Pope CA 3rd, Shin H, Straif K,
Shaddick G, Thomas M, van Dingenen R, van Donkelaar A, Vos T, Murray CJL,
Forouzanfar MH. Estimates and 25-year trends of the global burden of disease attrib-
utable to ambient air pollution: an analysis of data from the Global Burden of
Diseases Study 2015. Lancet 2017;389:1907–1918.
2. Burnett R, Chen H, Szyszkowicz M, Fann N, Hubbell B, Pope CA, Apte JS, Brauer M,
Cohen A, Weichenthal S, Coggins J, Di Q, Brunekreef B, Frostad J, Lim SS, Kan H,
Walker KD, Thurston GD, Hayes RB, Lim CC, Turner MC, Jerrett M, Krewski D,
Gapstur SM, Diver WR, Ostro B, Goldberg D, Crouse DL, Martin RV, Peters P,
Pinault L, Tjepkema M, van Donkelaar A, Villeneuve PJ, Miller AB, Yin P, Zhou M,
Wang L, Janssen NAH, Marra M, Atkinson RW, Tsang H, Quoc Thach T, Cannon JB,
Allen RT, Hart JE, Laden F, Cesaroni G, Forastiere F, Weinmayr G, Jaensch A, Nagel
G, Concin H, Spadaro JV. Global estimates of mortality associated with long-term ex-
posure to outdoor fine particulate matter. Proc Natl Acad Sci USA 2018;115:
9592–9597.
3. Lelieveld J, Pozzer A, Pöschl U, Fnais M, Haines A, Münzel, T. Comparison of mortal-
ity from ambient air pollution with other risk factors: a worldwide perspective.
Cardiov Res 2020;doi: 10.1093/cvr/cvaa025.
4. World Health Organization. Report of the WHO–China Joint Mission on Coronavirus
Disease 2019 (COVID-19). Geneva: WHO; 2020.
5. Miller MR. Oxidative stress and the cardiovascular effects of air pollution. Free Radic
Biol Med 2020;151:69–87.
6. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ,
Mehrkar A, Evans D, Inglesby, P, Cockburn J, McDonald HI, MacKenna B, Tomlinson
L, Douglas IJ, Rentsch RT, Mathur R, Wong AYS, Grieve R, Harrison D, Forbes H,
Schultze, A, Croker R, Parry J, Hester F, Harper S, Perera R, Evans SJW, Smeeth L,
Goldacre B. Factors associated with COVID-19-related death using OpenSAFELY.
Nature 2020;584:430–436.
7. Wu X, Nethery RC, Sabath MB, Braun D, Dominici F. Exposure to air pollution and
COVID-19 mortality in the United States. MedRxiv 2020; doi: 10.1101/2020.04.
05.20054502.
8. van Donkelaar A, Martin RV, Li C., Burnett RT. Regional estimates of chemical com-
position of fine particulate matter using a combined geoscience-statistical method
with information from satellites, models, and monitors. Environ Sci Technol 2019;53:
2595-2611.
9. World Health Organization. SARS (Severe Acute Respiratory Syndrome) Disease
Information. Geneva: WHO; 2020. https://www.who.int/ith/diseases/sars/en/
10. Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F. Cell entry mechanisms of
SARS-CoV-2. Proc Natl Acad Sci USA 2020;117:11727–11734.
11. Li Y, Liu B, Cui J, Wang Z, Shen Y, Xu Y, Yao K, Guan Y. Similarities and evolutionary
relationships of COVID-19 and related viruses. arXiv 2020;2020030316 (doi:
10.20944/preprints202003.0316.v1).
12. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang
CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X,
Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF,
Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat
origin. Nature 2020;579:270–273.
13. Chan-Yeun M, Xu R-H. SARS: epidemiology. Respiration 2003;8:S9–S14.
14. Yang M, Li CK, Li K, Hon KLE, Ng MHL, Chan PKS, Fok TF. Hematological findings in
SARS patients and possible mechanisms (Review). Int J Mol Med 2004;14:311–315
15. Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, Cowling BJ,
Lipsitch M, Leung GM, Estimating clinical severity of COVID-19 from the transmis-
sion dynamics in Wuhan, China. Nat Med 2020;26:506–510.
16. Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, Chen H, Wang D, Liu N, Liu D, Chen
G, Zhang Y, Li D, Li J, Lian H, Niu S, Zhang L, Zhang J. Characteristics of COVID-19
infection in Beijing. J Infect 2020;80:401–406.
17. Cui Y, Zhang Z-F, Froines J, Zhao J, Wang H, Yu S-Z, Detels R. Air pollution and
case fatality of SARS in the People’s Republic of China: an ecologic study. Environ
Health 2003;2:15.
18. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS,
Nigoghossian CD, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone
GW, Krumholz HM, Parikh SA. Cardiovascular considerations for patients, health
care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol
2020;75: 2352–2371.
19. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, and
the Northwell C-RC, Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J,
Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh
N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio
GA, Qiu M, Zanos TP. Presenting characteristics, comorbidities, and outcomes
among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA
2020;323:2052–2059.
20. Münzel T, Sorensen M, Gori T, Schmidt FP, Rao X, Brook J, Chen LC, Brook RD,
Rajagopalan S. Environmental stressors and cardio-metabolic disease: part I—epide-
miologic evidence supporting a role for noise and air pollution and effects of mitiga-
tion strategies. Eur Heart J 2017;38:550–556.
21. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global
health concern. Lancet 2020;395:470–473.
22. Wang B, Liu J, Fu S, Xu X, Li L, Ma Y, Zhou J, Yao J, Liu X, Zhang X, He X, Yan H,
Shi Y, Ren X, Niu J, Luo B, Zhang K. An effect assessment of airborne particulate
matter pollution on COVID-19: a multi-city study in China. MedRxiv 2020;https://doi.
org/10.1101/2020.04.09.20060137.
23. Yao Y, Pan J., Wang W, Liu X, Kan H., Meng X, Wang W. Spatial correlation of par-
ticulate matter pollution and death rate of COVID-19. MedRxiv 2020;https://doi.org/
10.1101/2020.04.07.20052142.
24. Conticini E, Frediani B, Caro D. Can atmospheric pollution be considered a co-factor
in extremely high level of SARS-CoV-2 lethality in Northern Italy? Environ Poll 2020;
261:114465.
25. Coronavirus Resource Center. Johns Hopkins University and Medicine, Baltimore,
MD, USA, 2020; https://coronavirus.jhu.edu.
26. Lelieveld J, Klingmüller K, Pozzer A, Burnett RT, Haines A, Ramanathan V. Effects of
fossil fuel and total anthropogenic emission removal on public health and climate.
Proc Natl Acad Sci USA 2019;116:7192–7197.
27. van Donkelaar A, Martin RV, Brauer M, Hsu NC, Kahn RA, Levy RC, Lyapustin A,
Sayer AM, Winker D.M. Global estimates of fine particulate matter using a combined
geophysical–statistical method with information from satellites, models, and moni-
tors. Environ Sci Technol 2016;50:3762–3772.
28. Ostro B. Outdoor Air Pollution: Assessing the Environmental Burden of Disease at National
and Local Levels. World Health Organization Protection of the Human Environment.
Geneva: WHO; 2004.
29. Guo JP, Zhang X-Y, Che H-Z, Gong S-L, An X, Cao C-X, Guang J, Zhang H, Wang
Y-Q, Zhang XC, Xue M, Li X-W. Correlation between PM concentrations and aero-
sol optical depth in eastern China. Atmos Environ 2009;43:5876–5886.
30. Zheng S, Cao CX, Singh RP. Comparison of ground based indices (API and AQI)
with satellite based aerosol products. Sci Total Environ 2014;488:398–412.
31. Center for International Earth Science Information Network, CIESIN, Columbia
University. Gridded Population of the World, Version 4 (GPWv4): Population Count,
Revision 11. Palisades, NY. NASA Socioeconomic Data and Applications Center
(SEDAC) 2020; https://doi.org/10.7927/H4JW8BX5.
32. Pope CA III, Bhatnagar A, McCracken JP, Abplanalp W, Conklin DJ, O’Tool T.
Exposure to fine particulate air pollution is associated with endothelial injury and sys-
temic inflammation. Circ Res 2016;119:1204–1214.
33. Münzel T, Gori, T, Al-Kindi S, Deanfield J, Lelieveld J, Daiber A, Rajagopalan S. Effects
of gaseous and solid constituents of air pollution on endothelial function. Eur Heart J
2018;39:3543–3550.






































































.34. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra
MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endothelii-
tis in COVID-19. Lancet 2020;395:1417–1418.
35. Tsai D-H, Riediker M, Berchet A, Paccaud F, Waeber G, Vollenweider P, Bochud M.
Effects of short- and long-term exposures to particulate matter on inflammatory
marker levels in the general population. Environ Sci Poll Res 2019;26:19697–19704.
36. Thurston GD, Kipen H, Annesi-Maesano I, Balmes J, Brook RD, Cromar K, De
Matteis S, Forastiere F, Forsberg B, Frampton MW, Grigg J, Heederik D, Kelly FJ,
Kuenzli N, Laumbach R, Peters A, Rajagopalan ST, Rich D, Ritz B, Samet JM,
Sandstrom T, Sigsgaard T, Sunyer J, Brunekreef B. A joint ERS/ATS policy statement:
what constitutes an adverse health effect of air pollution? An analytical framework.
Eur Respir J 2017;49:1600419.
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Translational perspective
COVID-19 infections and air pollution cause excess mortality from cardiovascular and pulmonary diseases. We estimated the fraction of COVID-
19 mortality attributable to the long-term exposure to ambient fine particulate air pollution (PM2.5). Global exposure to PM2.5 was characterized
based on satellite data, and the anthropogenic fraction was calculated with an atmospheric chemistry model. PM2.5 contributed 15% to COVID-
19 mortality worldwide, 27% in East Asia, 19% in Europe, and 17% in North America. Globally50–60% of the attributable, anthropogenic fraction
is related to fossil fuel use, and 70–80% in Europe/West Asia/North America, indicating the potential for substantial health benefits from reducing air
pollution exposure.
COVID-19 mortality attributable to air pollution 2253
